Jun 19, 2020
Global Spinal Muscular Atrophy Market Outlook to 2027 - Advent of Oral mRNA Splicer for Treatment
Jun 12, 2020
PTC Therapeutics Announces 2-year Data from Part 1 of SUNFISH and New Data from JEWELFISH Trials for Risdiplam in Patients with Spinal Muscular Atrophy
May 06, 2020
Ionis reports first quarter 2020 financial results and recent business achievements
Feb 26, 2020
Ionis provides fourth quarter and full year 2019 financial results
Feb 06, 2020
SUNFISH Pivotal Results for Risdiplam (RG7916) Demonstrate Medically Meaningful Benefit in Broadest Age Group of Patients Studied with Type 2 and 3 Spinal Muscular Atrophy
Jan 07, 2020
Ionis' neurological franchise marks year of achievement
Dec 24, 2019
Spinal Muscular Atrophy: Forecast in Asia-Pacific Markets to 2028
Nov 06, 2019
Ionis provides third quarter financial results and improved 2019 guidance
Oct 23, 2019
Ionis Chairman and CEO Stanley T. Crooke, M.D., Ph.D. to receive Massry Prize for contributions to biomedical sciences
Sep 30, 2019
Global Spinal Muscular Atrophy (SMA) Market Insights, Epidemiology and Market Forecast Report 2017-2019 & 2028
Sep 04, 2019
Locana appoints Kathie Bishop, Ph.D., as Chief Scientific Officer
Aug 07, 2019
Ionis Reports Second Quarter 2019 Financial Results
Jul 01, 2019
Biogen Announces New Data Further Establishing SPINRAZA® (nusinersen) as a Foundation of Care in Spinal Muscular Atrophy for a Broad Range of Patients
Jun 06, 2019
Physician Partners of America Doctor Treats Spinal Muscular Atrophy Patient
May 24, 2019
MDA Celebrates FDA Approval of Zolgensma for Treatment of Spinal Muscular Atrophy in Pediatric Patients
May 24, 2019
Newly Approved Spinal Muscle Atrophy Treatment Zolgensma is Based on Delivery System Discovered by Penn Gene Therapy Pioneer
May 24, 2019
AveXis Announces Innovative Zolgensma® Gene Therapy Access Programs for US Payers and Families
May 01, 2019
Positive clinical data at AAN 2019 reinforces Ionis' commitment to delivering life-changing medicines to patients with neurological diseases
Apr 25, 2019
Spinal Muscular Atrophy Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Apr 22, 2019
Patients living with Spinal Muscular Atrophy (SMA) in the province of Saskatchewan gain access to SPINRAZA(TM) (nusinersen)